MedTrace Logo

Administration of Probiotics in Cirrhotic Patients Listed for Liver Transplantation

NCT01735591 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2016-07-29

No results posted yet for this study

Summary

The aim of this study was to evaluate the impact of the administration of probiotics on outcomes of patients qualified for liver transplantation, both in the pre-transplant period and in the early postoperative period.

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo

Placebo, 1 capsule a day from inclusion until the date of liver transplantation

DIETARY_SUPPLEMENT

Probiotic

Capsules with 3x10\^9 colony forming units of: Lactococcus lactis PB 411 (50%), Lactobacillus casei PB 121 (25%), Lactobacillus acidophilus PB 111 (12,5%), Bifidobacterium bifidum PB 211 (12,5)

Sponsors & Collaborators

  • Ministry of Science and Higher Education, Poland

    collaborator OTHER_GOV

  • Medical University of Warsaw

    lead OTHER

Principal Investigators

  • Michał Grąt, M.D. · Medical University of Warsaw, Department of General, Transplant and Liver Surgery

  • Marek Krawczyk, Professor · Medical University of Warsaw, Department of General, Transplant and Liver Surgery

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01735591 on ClinicalTrials.gov